Early-life inflammatory markers and subsequent psychotic and depressive episodes between 10 to 28 years of age.

ALSPAC Depression Inflammation Life course Omics Psychotic experiences

Journal

Brain, behavior, & immunity - health
ISSN: 2666-3546
Titre abrégé: Brain Behav Immun Health
Pays: United States
ID NLM: 101759062

Informations de publication

Date de publication:
Dec 2022
Historique:
received: 27 09 2022
accepted: 01 10 2022
entrez: 24 10 2022
pubmed: 25 10 2022
medline: 25 10 2022
Statut: epublish

Résumé

Inflammation is implicated in depression and psychosis, including association of childhood inflammatory markers on the subsequent risk of developing symptoms. However, it is unknown whether early-life inflammatory markers are associated with the number of depressive and psychotic symptoms from childhood to adulthood. Using the prospective Avon Longitudinal Study of Children and Parents birth cohort (N = up-to 6401), we have examined longitudinal associations of early-life inflammation [exposures: interleukin-6 (IL-6), C-reactive protein (CRP) levels at age 9y; IL-6 and CRP DNA-methylation (DNAm) scores at birth and age 7y; and IL-6 and CRP polygenic risk scores (PRSs)] with the number of depressive episodes and psychotic experiences (PEs) between ages 10-28 years. Psychiatric outcomes were assessed using the Short Mood and Feelings Questionnaire and Psychotic Like Symptoms Questionnaires, respectively. Exposure-outcome associations were tested using negative binomial models, which were adjusted for metabolic and sociodemographic factors. Serum IL-6 levels at age 9y were associated with the total number of depressive episodes between 10 and 28y in the base model (n = 4835; β = 0.066; 95%CI:0.020-0.113; pFDR = 0.041) which was weaker when adjusting for metabolic and sociodemographic factors. Weak associations were observed between inflammatory markers (serum IL-6 and CRP DNAm scores) and total number of PEs. Other inflammatory markers were not associated with depression or PEs. Early-life inflammatory markers are associated with the burden of depressive episodes and of PEs subsequently from childhood to adulthood. These findings support a potential role of early-life inflammation in the aetiology of depression and psychosis and highlight inflammation as a potential target for treatment and prevention.

Identifiants

pubmed: 36277463
doi: 10.1016/j.bbih.2022.100528
pii: S2666-3546(22)00118-1
pmc: PMC9582583
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100528

Subventions

Organisme : Wellcome Trust
ID : 209176/Z/17/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_19009
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_15018
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M020827/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/V031260/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G9815508
Pays : United Kingdom

Informations de copyright

© 2022 The Author(s).

Déclaration de conflit d'intérêts

All authors have nothing to disclose.

Références

BMC Bioinformatics. 2012 May 08;13:86
pubmed: 22568884
Psychiatry Res. 1998 Nov 16;81(2):259-68
pubmed: 9858042
Am J Psychiatry. 2001 Apr;158(4):582-6
pubmed: 11282692
Brain Commun. 2022 Mar 08;4(2):fcac056
pubmed: 35402911
Mol Psychiatry. 2020 May;25(5):1130-1140
pubmed: 31435001
Brain Behav Immun. 2021 Jul;95:256-268
pubmed: 33794315
JAMA Psychiatry. 2014 Oct;71(10):1121-8
pubmed: 25133871
Schizophr Bull. 2011 Jan;37(1):84-93
pubmed: 19460881
J Clin Invest. 2003 Jun;111(12):1805-12
pubmed: 12813013
Clin Epidemiol. 2015 Jan 16;7:91-106
pubmed: 25653557
JAMA Psychiatry. 2021 Feb 1;78(2):161-170
pubmed: 33079133
JAMA. 1999 Dec 8;282(22):2131-5
pubmed: 10591334
Psychol Assess. 2014 Sep;26(3):752-62
pubmed: 24749755
Int J Epidemiol. 2015 Aug;44(4):1181-90
pubmed: 25991711
Arch Gen Psychiatry. 2008 Apr;65(4):409-15
pubmed: 18391129
Nat Rev Neurol. 2015 Apr;11(4):192-208
pubmed: 25686754
PLoS One. 2013 Apr 08;8(4):e60759
pubmed: 23579782
JAMA Netw Open. 2019 Jun 5;2(6):e196587
pubmed: 31251383
Schizophr Res. 2012 Sep;140(1-3):104-9
pubmed: 22789670
Dev Psychopathol. 2018 Aug;30(3):1145-1156
pubmed: 30068408
Psychol Med. 2018 Jul;48(9):1514-1522
pubmed: 29140226
Schizophr Res. 2021 Apr;230:69-76
pubmed: 33684738
Schizophr Res. 2019 Jul;209:32-39
pubmed: 31109737
Compr Psychiatry. 2020 Jan;96:152143
pubmed: 31707310
Brain Behav Immun. 2020 Jul;87:898-900
pubmed: 32014579
Int J Epidemiol. 2013 Feb;42(1):111-27
pubmed: 22507743
Brain Behav Immun. 2020 Nov;90:311-318
pubmed: 32920182
J Affect Disord. 2020 Jan 1;260:577-582
pubmed: 31539695
JAMA Psychiatry. 2022 May 1;79(5):498-507
pubmed: 35353173
Transl Psychiatry. 2019 Sep 18;9(1):233
pubmed: 31534116
Br J Psychiatry. 2021 Oct 06;:1-9
pubmed: 35049488
Nat Commun. 2019 Nov 8;10(1):5086
pubmed: 31704910
Front Immunol. 2018 Apr 13;9:754
pubmed: 29706967
Brain Behav Immun. 2017 Jan;59:253-259
pubmed: 27622678
Brain Behav Immun. 2021 Oct;97:176-185
pubmed: 34280516
Int J Epidemiol. 2013 Feb;42(1):97-110
pubmed: 22507742
Genome Biol. 2016 Dec 12;17(1):255
pubmed: 27955697
Am J Hum Genet. 2017 Jan 5;100(1):40-50
pubmed: 27989323
Mol Psychiatry. 2020 Jun;25(6):1286-1300
pubmed: 31019266
J Gerontol A Biol Sci Med Sci. 2021 Nov 15;76(12):2284-2292
pubmed: 33595649
Mol Psychiatry. 2020 Sep;25(9):2189-2199
pubmed: 31628416
Neurology. 2021 Dec 7;97(23):e2340-e2352
pubmed: 34789543
Biol Psychiatry Cogn Neurosci Neuroimaging. 2022 Jan;7(1):45-55
pubmed: 34271214
J Affect Disord. 2021 Nov 1;294:883-888
pubmed: 34375216
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
Wellcome Open Res. 2019 Mar 14;4:51
pubmed: 31020050
Psychoneuroendocrinology. 2018 Sep;95:43-49
pubmed: 29800779
Lancet. 2022 Aug 20;400(10352):617-631
pubmed: 35940184
Epigenetics. 2013 Feb;8(2):203-9
pubmed: 23314698
Brain Behav Immun. 2021 Feb;92:39-48
pubmed: 33221487
J Clin Invest. 2013 Mar;123(3):958-65
pubmed: 23454758
Psychiatry Res. 2020 Sep;291:113235
pubmed: 32599445
Wellcome Open Res. 2019 Aug 22;4:126
pubmed: 31595229
J Child Psychol Psychiatry. 2021 Dec;62(12):1462-1474
pubmed: 33778956

Auteurs

Amelia J Edmondson-Stait (AJ)

Translational Neuroscience PhD Programme, Centre for Clinical Brain Sciences, University of Edinburgh, UK.

Xueyi Shen (X)

Centre for Clinical Brain Sciences, University of Edinburgh, UK.

Mark J Adams (MJ)

Centre for Clinical Brain Sciences, University of Edinburgh, UK.

Miruna C Barbu (MC)

Centre for Clinical Brain Sciences, University of Edinburgh, UK.

Hannah J Jones (HJ)

National Institute for Health Research Bristol Biomedical Research Centre, At University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol, UK.
MRC Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, UK.
Centre for Academic Mental Health, Population Health Sciences, Bristol Medical School, University of Bristol, UK.

Veronique E Miron (VE)

Medical Research Council Centre for Reproductive Health, The Queen's Medical Research Institute, The University of Edinburgh, UK.

Judith Allardyce (J)

Centre for Clinical Brain Sciences, University of Edinburgh, UK.

James P Boardman (JP)

Centre for Clinical Brain Sciences, University of Edinburgh, UK.
Medical Research Council Centre for Reproductive Health, The Queen's Medical Research Institute, The University of Edinburgh, UK.

Stephen M Lawrie (SM)

Centre for Clinical Brain Sciences, University of Edinburgh, UK.

Andrew M McIntosh (AM)

Centre for Clinical Brain Sciences, University of Edinburgh, UK.

Golam M Khandaker (GM)

MRC Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, UK.
Centre for Academic Mental Health, Population Health Sciences, Bristol Medical School, University of Bristol, UK.

Alex S F Kwong (ASF)

Centre for Clinical Brain Sciences, University of Edinburgh, UK.

Heather C Whalley (HC)

Centre for Clinical Brain Sciences, University of Edinburgh, UK.

Classifications MeSH